Skip to content

News Category: Health & Medical

OptraSCAN’s Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time

By asianet

OptraSCAN(R) [https://www.optrascan.com/], the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent – No 2020/0334814 A1 by the United States Patent and Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze pathological samples simultaneously. This will benefit the end-user to view the whole slide scanned … Continued

Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand

By asianet

Medison Pharma [https://www.medisonpharma.com/] (“Medison”), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, today announced the addition of new markets to its multi-territorial agreement with Immunocore Holdings plc [https://www.immunocore.com/] (Nasdaq: IMCR) (“Immunocore”), a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor … Continued

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

By asianet

— European Commission Decision Anticipated within Approximately 60 Days — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical company, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion … Continued

Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology

By asianet

-Emerald study met both its primary end points of Progression-free survival (PFS) in overall population and in ESR1 mutated patients -PFS rate at 12 months with elacestrant was 22.32% vs. 9.42% with SOC in the overall population, and 26.76% vs. 8.19% in the ESR1 mutation population -Data demonstrated elacestrant significantly reduced the risk of disease … Continued

Labaid Ltd. (Diagnostics) and Labaid Cancer Hospital & Super Specialty Center partner with Darwinbox to achieve total Digital Transformation

By asianet

Labaid Ltd. (Diagnostics) and Labaid Cancer Hospital & Super Specialty Center, a part of the Labaid Group, have partnered with Darwinbox to achieve total digital transformation by 2026. This is in line with their vision of becoming Bangladesh’s ‘trusted healthcare provider’ and aggressive business growth. Darwinbox’s addition is specifically to supercharge the HR operations and … Continued

Abl And Odimma Therapeutics Join Forces In Personalized Cancer Immunotherapy

By asianet

ABL Europe (ABL) [https://www.abl-biomanufacturing.com/ ], a pure play contract development and manufacturing organization (CDMO) specialized in development and manufacturing of virus for vaccine candidates, gene and cancer therapies and Odimma Therapeutics (Odimma) [http://odimma-therapeutics.com/?msclkid=8fec39dac63311ec9872f2daaf949638 ] a young biotechnological company focusing on personalized cancer immunotherapy, announced that they have signed a development agreement. ABL will manufacture the … Continued

Pocared Diagnostics, an Israeli rapid infectious diseases diagnostics leader, secures a EUR 22 million EIB backing for completion of the development and commercialization of its rapid testing system

By asianet

– First EIB support for medtech investment in Israel – Financing to accelerate development of rapid testing system to improve infectious disease diagnosis and antibiotics stewardship – Automated phenotypic testing, revolutionizing infectious diseases diagnostics from sample to answer Research and development of fully automated testing of bacteria and infectious diseases by POCARED Diagnostics will be … Continued

Regional UK Laboratory Information Management System Contract Awarded to Citadel Health

By asianet

A contract for the implementation of a new Laboratory Information Management System (LIMS) across all NHS pathology services in Lancashire & South Cumbria has been awarded to Citadel Health ( https://citadelhealth.co.uk/contract-for-regional-uk-laboratory-information-management-system-awarded-to-citadel-health/). The new single LIMS will replace four standalone systems across eight hospital sites, cutting costs via a common platform linking all laboratories for the … Continued

DetectedX Launches Radiology Online Learning Platform to the U.S. Market at SBI

By asianet

– The Intelligent Interactive Educational Technology from DetectedX has Shown a 34% Improvement in the Accuracy of Diagnosing Difficult Cases DetectedX (https://detectedx.com/) announced today that it will launch its Radiology Online Learning Platform to radiologists in the United States at the SBI/ACR Breast Imaging Symposium 2022, in Savannah, GA, May 16-19 (Booth #221). Designed to … Continued

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

By asianet

Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics. Besides Bora, investors into the new entity include Taishin Healthcare Limited … Continued